Regulatory Perspectives on Deviation Severity
Regulatory Perspectives on Deviation Severity How Regulatory Authorities View and Evaluate Protocol Deviation Severity Why Regulatory Classification of Deviations Matters Protocol deviations are a routine part of clinical trial conduct. However, how these deviations are classified—as major or minor—has critical implications under the scrutiny of regulatory bodies such as the FDA, EMA, MHRA, and others….